Royce & Associates’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,412
| Closed | -$476K | – | 919 |
|
|
2024
Q1 | $476K | Sell |
11,412
-1,533
| -12% | -$63.9K | ﹤0.01% | 796 |
|
|
2023
Q4 | $326K | Buy |
12,945
+8,978
| +226% | +$226K | ﹤0.01% | 819 |
|
|
2023
Q3 | $130K | Buy |
3,967
+2,184
| +122% | +$71.4K | ﹤0.01% | 888 |
|
|
2023
Q2 | $104K | Buy |
+1,783
| New | +$104K | ﹤0.01% | 898 |
|